Időskori makuladegeneráció: vizsgálatok itt: Spanyolország

In Spanyolország 21 Also abroad 220

21 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.

2. fázisNot yet taking people in Spanyolország
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Where
Barcelona, Burjassot, L'hospitalet De Llobregat, Madrid, Valencia
Életkor
60 év and over
People
240 worldwide
Run by
ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06990269 · EU 2025-521779-30-00
3. fázisTaking people
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Where
Barcelona, Madrid, Pamplona, Sant Cugat del Vallès, Santiago de Compostela
Életkor
50 év and over
People
304 worldwide
Run by
Amgen
See details and how to joinNCT07614776 · EU 2025-523500-72-00
2. fázisTaking people
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Where
Burjassot, Cordoba, Sant Cugat del Vallès, Santiago De Compostela
Életkor
50 év and over
People
272 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07441642 · EU 2025-523704-77-00
3. fázisTaking people
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Where
Madrid, Sevilla, Valencia
Életkor
50 év and over
People
250 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06847542 · EU 2024-516924-32-00
3. fázisTaking people
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Where
Barcelona, Burjassot, Cordoba, L'hospitalet De Llobregat, Madrid, Sevilla, Terrassa, Valencia, Zaragoza
Életkor
50 év to 85 év
People
975 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06541704 · EU 2023-509547-27-00
2/3. fázisTaking people
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Where
Barcelona, Burjassot, Cordoba, Madrid, Majadahonda, Pamplona, Sant Cugat del Vallès, Sevilla, Zaragoza
Életkor
60 év and over
People
274 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06635148 · EU 2022-500747-21-00
3. fázisTaking people
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Where
Barcelona, Cordoba, Donostia, Madrid, Majadahonda, Oviedo, Sevilla, Valencia, Zaragoza
Életkor
50 év and over
People
561 worldwide
Run by
AbbVie
See details and how to joinNCT07007065 · EU 2024-512298-28-00
3. fázisTaking people
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Where
Barcelona, Burjassot, Cordoba, L'hospitalet De Llobregat, Madrid, Majadahonda, Oviedo, Pamplona, Sant Cugat del Vallès
Életkor
50 év and over
People
1000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT03683251 · EU 2023-507131-38-00
3. fázisFut, nem toboroz
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Where
Barcelona, Santiago de Compostela, Seville
Életkor
50 év and over
People
480 worldwide
Run by
4D Molecular Therapeutics
See details and how to joinNCT07064759
2/3. fázisTaking people
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Where
Barcelona, Madrid
Életkor
50 év and over
People
960 worldwide
Run by
EyeBiotech Ltd.
See details and how to joinNCT07440225
2. fázisFut, nem toboroz
ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study
Where
Barcelona, Madrid, Pamplona
Életkor
55 év and over
People
225 worldwide
Run by
Gyroscope Therapeutics Limited
See details and how to joinNCT05481827 · EU 2024-510946-15-00
3. fázisNot yet taking people in Spanyolország
Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).
Where
Barcelona
Életkor
50 év to 120 év
People
210 worldwide
Run by
King's College Hospital NHS Trust
See details and how to joinNCT04663750 · EU 2023-504751-28-00
2/3. fázisTaking people
A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)
Where
Barcelona, Burjassot, Sant Cugat Del Valles, Santiago De Compostela, Zaragoza
Életkor
18 év and over
People
250 worldwide
Run by
Eyebiotech Limited
See details and how to join2025-524894-17-00
2. fázisTaking people
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Where
Barcelona, Bilbao, Cordoba, Majadahonda, Sevilla, Valencia, Zaragoza
Életkor
55 év and over
People
324 worldwide
Run by
ONL Therapeutics
See details and how to joinNCT06659445 · EU 2024-513174-22-00
2/3. fázisTaking people
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Where
Barcelona, Burjassot -(Valencia)
Életkor
50 év and over
People
960 worldwide
Run by
EyeBiotech Ltd.
See details and how to joinNCT07496567
2/3. fázisTaking people
A randomized double-masked, multicenter, 3 arm pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8748 in participants with neovascular age-related macular degeneration (NVAMD)
Where
Barcelona, Majadahonda
Életkor
18 év and over
People
130 worldwide
Run by
Eyebiotech Limited
See details and how to join2025-524575-22-00
4. fázisTaking people
Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material
Where
Albacete, Barcelona, Bilbao, Burjassot, Córdoba, Madrid, Majadahonda, Oviedo, Valencia, Valladolid
Életkor
50 év and over
People
100
Run by
Biobizkaia Health Research Institute
See details and how to joinNCT07403825
No phaseTaking people
Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
Where
Barcelona
Életkor
55 év to 99 év
People
200 worldwide
Run by
Medical University of Vienna
See details and how to joinNCT06351657
No phaseTaking people
Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
Where
Barcelona
Életkor
55 év to 99 év
People
500 worldwide
Run by
Medical University of Vienna
See details and how to joinNCT06351670
No phaseCsak meghívásos
Implementation of the Intravitreal Injection Administered by Nurses
Where
Sabadell
Életkor
18 év and over
People
200
Run by
Corporacion Parc Tauli
See details and how to joinNCT06511700
2. fázisNot yet taking people in Spanyolország
Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
Where
Barcelona, Cordoba, Las Palmas de Gran Canaria, L'hospitalet De Llobregat, Madrid, Majadahonda, Santiago de Compostela
Életkor
50 év and over
People
865 worldwide
Run by
AbbVie
See details and how to joinNCT03999801 · EU 2023-505750-17-00